Comparison of positron emission tomography/computed tomography imaging and ultrasound in surveillance of head and neck cancer - The 3-year experience of the ENT Department in Poznan

Reports of Practical Oncology and Radiotherapy

Volumn 16, Issue 5, 2011, Pages 184-188

  Wierzbicka, Małgorzata ^a   Popko, Mariola ^a   Piskadło, Karolina ^a   Czepczyński, Rafał ^a,b   Stankowska, Aleksandra ^a   Pietka, Tomasz ^c   Dziuk, Mirosław ^c   Szyfter, Witold ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Greater Poland Cancer Centre   (Poland)

^c MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Head and neck squamous cell carcinoma; PET CT; US

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; ULTRASOUND;

EID: 80053308805     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2011.04.007     Document Type: Article

References (21)

1. Parker S.L., Tong T., Bolden S. Cancer statistics. CA Cancer J Clin 1996, 196(46):5-27.
2. Vokes E.E., Weichselbaum R.R., Lippman S.M., et al. Head and neck cancer. N Engl J Med 1993, 328:184-194.
3. Yoon D.Y., Hwang H.S., Chang S.K., et al. CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 2009, 19:634-642.
4. Comoretto M., Balestreri L., Borsatti E., Cimitan M., Franchin G., Lise M. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 2008, 249:203-211.
5. Adams S., Baum R.P., Stuckensen T., Bitter K., Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998, 25:1255-1260.
6. de Bree R., Deurloo E.E., Snow G.B., Leemans C.R. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000, 110(3pt1):397-401.
7. Yonetsu K., Sumi M., Izumi M., Ohki M., Eida S., Nakamura T. Contribution of Doppler sonography blood flow information to the diagnosis of metastatic cervical nodes in patients with head and neck cancer: assessment in relation to anatomic levels of the neck. AJNR 2001, 22:163-169.
8. Chikui T., Yonetsu K., Nakamura T. Multivariate feature analysis of sonographic findings of metastatic cervical lymph nodes: contribution of blood flow features revealed by power Doppler sonography for predicting metastasis. AJNR 2000, 21:561-567.
9. Vassallo P., Edel G., Roos N., Naguib A., Peters P.E. In vitro high-resolution ultrasonography of benign and malignant lymph nodes, a sonographic-pathologic correlation. Invest Radiol 1993, 28:698-705.
10. de Bondt R.B., Nelemans P.J., Hofman P.A. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, UsgFNAC, CT and MR imaging. Eur J Radiol 2007, 64:266-272.
11. Kapoor V., Fukui M.B., McCook B.M. Role f 18F-FDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls. AJR 2005, 184:589-597.
12. Goodwin W.J. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?. Laryngoscope 2000, 110:1-18.
13. Schwarz D.L., Barker J., Chansky K. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma: too much for too little?. Head Neck 2003, 25:990-999.
14. de Bondt R.B.J., Nelemans P.J., Hofman P.A.M., et al. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, UsgFNAC, CT and MR imaging. Eu J Radiol 2007, 64:266-272.
15. Abgral R., Querellou S., Petard G., et al. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?. J Nucl Med 2009, 50:24-29.
16. Lowe V.J., Boyd J.H., Dunphy F.R. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000, 18:658.
17. Ryan W.R., Fee W.E., Le Q.T., Pinto H.A. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005, 115:645-650.
18. Fischbein N.J., Assar O.S., Caputo G.R. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detection residual/recurrent squamous cell carcinoma of the head and neck. AJNR 1998, 19:1189-1196.
19. Hwang H.S., Perez D.A., Orloff L.A. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer. Laryngoscope 2009, 119:1958-1965.
20. Schoder H., Yeung H.W., Gonen M., Kraus D., Larson S.M. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004, 231:65-72.
21. Fukui M.B., Blodgett T.M., Meltzer C.C. PET/CT imaging in recurrent head and neck cancer. Seminars Ultrasound CT MRI 2003, 24(3):157-163.